Top Markets
#1 MowCat MowCat +777.19%
#2 龙虾 (Lobster) 龙虾 (Lobster) +86.97%
#3 Akedo Akedo +43.38%
#4 Magma Finance Magma Finance +43.13%
#5 MarsCoin MarsCoin +30.95%
#6 SIXSEVEN SIXSEVEN +29.89%
#7 DeXe DeXe +28.27%
#8 Cortex Cortex +26.09%
#9 Staked ZIG Staked ZIG +19.55%
#10 Zignaly Zignaly +19.44%
Coin of the day
MowCat MowCat
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Seaport Therapeutics, Inc. Common Stock Seaport Therapeutics, Inc. Common Stock

Seaport Therapeutics, Inc. Common Stock

SPTX
Classifica tra le azioni #8294
Seaport Therapeutics, Inc. is a developing biopharmaceutical enterprise... Seaport Therapeutics, Inc. is a developing biopharmaceutical enterprise currently undergoing clinical trials, focused on creating groundbreaking treatments for neuropsychiatric conditions. The company is primarily engaged in tackling disorders like depression and anxiety, utilizing its unique Glyph technology. This exclusive platform is engineered to allow for oral administration of drugs, circumventing initial metabolic processing in the liver, and thereby reducing the risk of liver enzyme elevations, hepatotoxicity, and other potential adverse reactions. Every therapeutic agent in their pipeline incorporates this advanced platform, with all research and development efforts exclusively dedicated to neuropsychiatric applications. Founded in 2024 and situated in Boston, Massachusetts, the company connects with medical professionals and influential experts across the healthcare and neuropsychiatric sectors.
Prezzo delle azioni
$24.37
Capitalizzazione di mercato
$1.30B
Variazione (1 giorno)
-7.16%
Variazione (1 anno)
-
Paese
US
Scambia Seaport Therapeutics, Inc. Common Stock (SPTX)

Categoria

Healthcare
Rapporto P/B per Seaport Therapeutics, Inc. Common Stock (SPTX)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Seaport Therapeutics, Inc. Common Stock, il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per Seaport Therapeutics, Inc. Common Stock da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH